RecruitingNCT00178594

Evaluation of Hemostasis in Bleeding and Thrombotic Disorders

Evaluation of Hemostasis in Bleeding and Thrombotic Disorders Using the Roteg Analyzer and the Thrombin Generation Assay

Sponsor

The University of Texas Health Science Center, Houston

Enrollment

1,000 participants

Start Date

Oct 1, 2002

Study Type

OBSERVATIONAL

Conditions

Blood Coagulation Disorders, Inherited Thrombotic Disorder

Summary

The objective of this study will be to assess the coagulation system in-vitro in a variety of bleeding and clotting disorders using the ROTEG analyzer and the thrombin generation assay.

Eligibility

Min Age: 1 DayMax Age: 98 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with blood coagulation disorders, inherited and thrombotic disorder. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 1 Day to 98 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(2)

The Univerisity of Texas Health Science Center at Houston

Houston, Texas, United States

UT Physicians Women's Center-Texas Medical Center

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT00178594